Immune control of HIV-1 after early treatment of acute infection
By E. Rosenberg, M. Altfeld, Samuel H. Poon, M. N. Phillips, B. Wilkes, Robert L. Eldridge, G. Robbins, R. D’Aquila, P. Goulder, Bruce D. Walker. Nature, 2000
1,091 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology, Virology
View Paper: https://www.semanticscholar.org/paper/8555f105b95c52a58e00de6ad4c9918897716795
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Virology
Citations in the corpus
- Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters (2011, background): “While high viral loads during acute HIV infection are typically described [33,34], low plasma levels of HIV RNA have also been reported [7,35].”
- Brief but efficient: acute HIV infection and the sexual transmission of HIV. (2004, background): “[32] of acute antiretroviral treatment for individual patients who”
- Dynamic multidrug therapies for hiv: optimal and sti control approaches. (2004, background): “reported on eight subjects in an interruption study [23].”
- Treatment of acute hepatitis C with interferon alfa-2b. (2001, background): “First, in patients with acute human immunodeficiency virus (HIV) infection, antiretroviral therapy sufficiently decreased the viral load to allow the patients' immune systems subsequently to control viral replication.(14)-(15) Second, early control of viral load in a murine model of lymphocytic chor”
- Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level (2002, background): “preservation of HIV-1-specific CTL cell responses,(638) even after ceasing treatment.(638,827)”
- Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies (2005, background): “Subject AC10 was seropositive at the time of virus isolation, but Western blot reactivity indicated a very early stage of seroconversion (73).”
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study (2013, result): “PTCs have very low HIV reservoir levels that, in some cases, continue to decline for years after treatment interruption Overall, the PBMC-associated HIV-1 DNA levels in the PTCs during the infection control (median 1.71 log copies/106 PBMC, Table 1) were similar to those in the HICs and much lower t”